IQ Capital is a dedicated deep tech venture capital firm investing in early-stage B2B startups across Europe that are commercializing IP-rich, breakthrough technologies. The firm focuses on partnering with founders pushing the frontiers of science and engineering, particularly in AI, computing, and biology.
About IQ Capital
IQ Capital is a Cambridge, UK-based deep tech venture firm investing in early-stage technical companies across AI, machine learning, quantum, and computational sciences, with a thesis built around technically defensible IP and strong founding teams from Cambridge, Oxford, and other research universities. The fund writes initial checks of roughly $1M to $10M from seed through Series B, can lead rounds, and has a track record including Privitar, Speechmatics, and other deep tech names. Healthcare exposure is partial and concentrated in AI for life sciences, drug discovery, medical imaging, and computational biology rather than digital health services. AI focus is the primary thesis. Founders best suited are technical UK or European CEOs with strong scientific or engineering credentials, often emerging from a research lab, building deep tech companies in AI-enabled healthcare or life sciences. Founders who do not fit include digital health services without a deep tech angle, therapeutics-only biotech, consumer wellness, and any team without strong technical defensibility. Geographic preference is UK and Europe with a Cambridge bias. The entry path is warm introduction through a Cambridge-area operator, a portfolio CEO, or a co-investor at funds like Amadeus Capital or Octopus Ventures. LinkedIn outreach to a partner with a focused technical and IP summary is a reasonable secondary option. Expect deep technical and IP diligence, scientific advisor reviews, and a long-term board partner who will engage on technical strategy. Founders should plan for a thorough but supportive process.
Founder reviews
Other portfolio companies
Companies in IQ Capital's portfolio not currently in our directory.
- DaltonTx · 2025
- IMU Biosciences · 2026
- Trogenix · 2025
- Closed Loop Medicine
- Neurovalens
- Baseimmune
- Mytos
- Wobble Genomics · 2024
- AiM Medical Robotics
- Biobeats
Team
Pitch / review this investor
Have you raised from IQ Capital? Founders only — share your honest experience (anonymous OK, moderated before publishing).